Cargando…

A Prognostic Model Based on NSUN3 Was Established to Evaluate the Prognosis and Response to Immunotherapy in Liver Hepatocellular Carcinoma

It is difficult for traditional therapies to further improve the prognosis of hepatocellular carcinoma (LIHC), and immunotherapy is considered to be a promising approach to overcome this dilemma. However, only a minority of patients benefit from immunotherapy, which greatly limits its application. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Jianlin, Kuang, Junxi, Yang, Yi, Zhang, Lei, Leng, Bo, She, Risheng, Zou, Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129436/ https://www.ncbi.nlm.nih.gov/pubmed/37114236 http://dx.doi.org/10.1155/2023/6645476

Ejemplares similares

NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

Novel lipometabolism biomarker for chemotherapy and immunotherapy response in breast cancer
por: Zhang, Lei, et al.
Publicado: (2022)

Multi-omics analysis of expression and prognostic value of NSUN members in prostate cancer
por: Sun, Guangyu, et al.
Publicado: (2022)

Identification of Immune-Related Genes for Establishment of Prognostic Index in Hepatocellular Carcinoma
por: Li, Yinfang, et al.
Publicado: (2021)

Reorganization of the Landscape of Translated mRNAs in NSUN2-Deficient Cells and Specific Features of NSUN2 Target mRNAs
por: Kossinova, Olga A., et al.
Publicado: (2022)

M6A modification of circNSUN2 promotes colorectal liver metastasis
por: He, Rong-Zhang, et al.
Publicado: (2019)

Differential expression of m(5)C RNA methyltransferase genes NSUN6 and NSUN7 in Alzheimer’s disease and traumatic brain injury
por: PerezGrovas-Saltijeral, Adriana, et al.
Publicado: (2023)

Expression of the RNA methyltransferase Nsun5 is essential for developing cerebral cortex
por: Chen, Peipei, et al.
Publicado: (2019)

Agenesis and Hypomyelination of Corpus Callosum in Mice Lacking Nsun5, an RNA Methyltransferase
por: Yuan, Zihao, et al.
Publicado: (2019)

NSUN2 Promotes Tumor Progression and Regulates Immune Infiltration in Nasopharyngeal Carcinoma
por: Tong, Xinya, et al.
Publicado: (2022)

Aging-related features predict prognosis and immunotherapy efficacy in hepatocellular carcinoma
por: Hong, Ting, et al.
Publicado: (2022)

Nsun4 and Mettl3 mediated translational reprogramming of Sox9 promotes BMSC chondrogenic differentiation
por: Yang, Lin, et al.
Publicado: (2022)

The RNA Methyltransferase NSUN2 and Its Potential Roles in Cancer
por: Chellamuthu, Anitha, et al.
Publicado: (2020)

Aberrant NSUN2-mediated m(5)C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma
por: Sun, Zhen, et al.
Publicado: (2020)

A scoring model based on ferroptosis genes for prognosis and immunotherapy response prediction and tumor microenvironment evaluation in liver hepatocellular carcinoma
por: Gao, Lei, et al.
Publicado: (2021)

A Differentiation-Related Gene Prognostic Index Contributes to Prognosis and Immunotherapy Evaluation in Patients with Hepatocellular Carcinoma
por: Xiao, Jingjing, et al.
Publicado: (2022)

Comprehensive analysis and validation of SNX7 as a novel biomarker for the diagnosis, prognosis, and prediction of chemotherapy and immunotherapy response in hepatocellular carcinoma
por: Chen, Jianlin, et al.
Publicado: (2023)

RNA methyltransferase NSUN2 promotes stress-induced HUVEC senescence
por: Cai, Xiaoyu, et al.
Publicado: (2016)

Mammalian NSUN2 introduces 5-methylcytidines into mitochondrial tRNAs
por: Shinoda, Saori, et al.
Publicado: (2019)

NSUN2 introduces 5-methylcytosines in mammalian mitochondrial tRNAs
por: Van Haute, Lindsey, et al.
Publicado: (2019)

ELOVLs Predict Distinct Prognosis Value and Immunotherapy Efficacy In Patients With Hepatocellular Carcinoma
por: Zhang, Yu, et al.
Publicado: (2022)

Development of a prognostic model based on anoikis-related genes for predicting clinical prognosis and immunotherapy of hepatocellular carcinoma
por: Pang, Mu, et al.
Publicado: (2023)

Establishing a signature based on immunogenic cell death-related gene pairs to predict immunotherapy and survival outcomes of patients with hepatocellular carcinoma
por: Ma, Jianying, et al.
Publicado: (2022)

Knocking down NSUN5 inhibits the development of clear cell renal cell carcinoma by inhibiting the p53 pathway
por: Li, Lei, et al.
Publicado: (2023)

Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer
por: Ortiz-Barahona, Vanessa, et al.
Publicado: (2023)

Bibliometric study of immunotherapy for hepatocellular carcinoma
por: Li, Zhiyi, et al.
Publicado: (2023)

The NSUN5-FTH1/FTL pathway mediates ferroptosis in bone marrow-derived mesenchymal stem cells
por: Liu, Jie, et al.
Publicado: (2022)

Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons
por: Luo, Yi, et al.
Publicado: (2022)

A Lamin Family-Based Signature Predicts Prognosis and Immunotherapy Response in Hepatocellular Carcinoma
por: Yang, Yongyu, et al.
Publicado: (2022)

The nucleolar RNA methyltransferase Misu (NSun2) is required for mitotic spindle stability
por: Hussain, Shobbir, et al.
Publicado: (2009)

The RNA–Methyltransferase Misu (NSun2) Poises Epidermal Stem Cells to Differentiate
por: Blanco, Sandra, et al.
Publicado: (2011)

Sequence- and structure-specific cytosine-5 mRNA methylation by NSUN6
por: Selmi, Tommaso, et al.
Publicado: (2020)

NSun2 promotes cell migration through methylating autotaxin mRNA
por: Xu, Xin, et al.
Publicado: (2021)

Comprehensive bioinformatic analysis of MMP1 in hepatocellular carcinoma and establishment of relevant prognostic model
por: Dai, Lei, et al.
Publicado: (2022)

A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma
por: Fu, Xing, et al.
Publicado: (2022)

Establishment of lactate-metabolism-related signature to predict prognosis and immunotherapy response in patients with colon adenocarcinoma
por: Zou, Zhengrong, et al.
Publicado: (2022)

Cuproptosis-related prognostic signatures predict the prognosis and immunotherapy in HCC patients
por: Peng, Hong, et al.
Publicado: (2023)

The Prognostic Model Established by the Differential Expression Genes Based on CD8(+) T Cells to Evaluate the Prognosis and the Response to Immunotherapy in Osteosarcoma
por: Chen, Yu, et al.
Publicado: (2023)

Establishment and validation of a ferroptosis-related prognostic signature for hepatocellular carcinoma
por: He, Yixian, et al.
Publicado: (2023)

Analysis of risk factors of hepatocellular carcinoma and establishment of a clinical prognosis model
por: Ge, Xin-Yu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ogfbbhunb34qaqar230ptrodam